Centres pour le contrôle et la prévention des maladies

Résumé

Les Centres pour le contrôle et la prévention des maladies (Centers for Disease Control and Prevention ou CDC) forment ensemble la principale agence fédérale des États-Unis en matière de protection de la santé publique. Les centres produisent des informations dans le but d'améliorer les décisions gouvernementales en matière de santé. Ils promeuvent également la santé par des partenariats avec les départements de la santé des différents États américains et d'autres organisations. Les CDC ont le statut d'agence du département de la Santé et des Services sociaux des États-Unis. Leur quartier général est situé dans le comté de DeKalb, près d'Atlanta en Géorgie. Rochelle Walensky en est la directrice depuis le . Fonctions Coordonnant tous les systèmes de surveillance épidémiologique des États-Unis, les CDC produisent de l’information qui permet d’attirer l’attention des décideurs politiques et de l'opinion publique sur le développement et l’application de la prévention des ma

Source officielle

https://fr.wikipedia.org/wiki/Centres_pour_le_contr%C3%B4le_et_la_pr%C3%A9vention_des_maladies

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Publications associées (12)

Publications associées

Chargement

Personnes associées

Chargement

Unités associées

Chargement

Concepts associés (119)

Concepts associés

Chargement

Cours associés (3)

Cours associés

Chargement

Séances de cours associées (3)

Séances de cours associées

Chargement

Precision Global Health - The case of Ebola: a scoping review

Gérard Escher

Background The 2014-2016 Ebola outbreak across West Africa was devastating, acting not only as a wake-up call for the global health community, but also as a catalyst for innovative change and global action. Improved infectious disease monitoring is the stepping-stone toward better disease prevention and control efforts, and recent research has revealed the potential of digital technologies to transform the field of global health. This scoping review aimed to identify which digital technologies may improve disease prevention and control, with regard to the 2014-2016 Ebola outbreak in West Africa. Methods A search was conducted on PubMed, EBSCOhost. and Web of Science, with search dates ranging from 2013 (01/01/2013) - 2017 (13/06/2017). Data was extracted into a summative table and data synthesized through grouping digital technology domains, using narrative and graphical methods. Findings The scoping review identified 82 full-text articles, and revealed big data (48%, n=39) and modeling (26%, n= 21) technologies to be the most utilized within the Ebola outbreak. Digital technologies were mainly used for surveillance purposes (90%, n =74), and key challenges were related to scalability and misinformation from social media platforms. Interpretation Digital technologies demonstrated their potential during the Ebola outbreak through: more rapid diagnostics, more precise predictions and estimations, increased knowledge transfer, and raising situational awareness through mHealth and social media platforms such as Twitter and Weibo. However, better integration into both citizen and health professionals' communities is necessary to maximise the potential of digital technologies.

2019

Chargement

Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research

Deepak Gupta, Sean Lewis Hill, William John Stewart

Elsevier2017

Chargement

Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives

Nimisha Chaturvedi, Jacques Fellay

Tuberculosis is an ancient human disease, estimated to have originated and evolved over thousands of years alongside modern human populations. Despite considerable advances in disease control, tuberculosis remains one of the world's deadliest communicable diseases with 10 million incident cases and 1·8 million deaths in 2015 alone based on the annual WHO report, due to inadequate health service resources in less-developed regions of the world, and exacerbated by the HIV/AIDS pandemic and emergence of multidrug-resistant strains of Mycobacterium tuberculosis. Recent findings from studies of tuberculosis infection and of patients with Mendelian predisposition to severe tuberculosis have started to reveal human loci influencing tuberculosis outcomes. In this Review, we assess the current understanding of the contribution of host genetics to disease susceptibility and to drug treatment. Despite remarkable progress in technology, only a few associated genetic variants have so far been identified, strongly indicating the need for larger global studies that investigate both common and under-represented rare variants to develop new approaches to combat the disease. Pharmacogenomic discoveries are also likely to lead to more efficient drug design and development, and ultimately safer and more effective therapies for tuberculosis.

2018

Chargement